首页> 外文OA文献 >EpideMiology and control measures of outBreaks due to Antibiotic-Resistant orGanisms in EurOpe (EMBARGO): a systematic review protocol
【2h】

EpideMiology and control measures of outBreaks due to Antibiotic-Resistant orGanisms in EurOpe (EMBARGO): a systematic review protocol

机译:EurOpe(EMBARGO)中的抗生素抗性或基因缺陷导致的疾病流行病学和控制措施:系统的审查方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

INTRODUCTION: Improving our understanding of outbreaks due to antibiotic-resistant bacteria (ARB) and their control is critical in the current public health scenario. The threat of outbreaks due to ARB requires multifaceted efforts. However, a global overview of epidemiological characteristics of outbreaks due to ARB and effective infection control measures is missing. In this paper, we describe the protocol of a systematic review aimed at mapping and characterising the epidemiological aspects of outbreaks due to ARB and infection control measures in European countries. METHODS AND ANALYSIS: The databases MEDLINE, Web of Knowledge and Cochrane library will be searched using a 3-step search strategy. Selection of articles for inclusion will be performed by 2 reviewers using predefined eligibility criteria. All study designs will be included if they report an outbreak and define the microbiological methods used for microorganism identification. The target bacteria will be methicillin-resistant and vancomycin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, ceftazidime-resistant and carbapenem-resistant Acinetobacter baumannii, ceftazidime-resistant and carbapenem-resistant Pseudomonas aeruginosa, ciprofloxacin-resistant Escherichia coli, extended-spectrum beta-lactamase-producing E. coli and Klebsiella pneumoniae, carbapenem-resistant and carbapenamase-producing Enterobacteriaceae. Data will be extracted using a tailored pilot tested form and the quality of reporting will be assessed using the ORION (Outbreak Reports and Intervention Studies Of Nosocomial infections) tool. Data will be synthesised and reported by the type of ARB, setting and country. Infection control measures and bundles of measures will be described. The effectiveness will be reported as defined by the authors. Regression analysis will be used to define independent factors associated with outbreaks' control. Heterogeneity between studies will be assessed by forest plots and I(2) statistics. ETHICS AND DISSEMINATION: Ethical approval is not applicable for this study. Findings will be disseminated through journal publication and conference presentations and talks.
机译:简介:在目前的公共卫生情况下,增进我们对抗生素耐药菌(ARB)爆发及其控制的认识至关重要。由于ARB而引起的爆发威胁需要多方面的努力。但是,缺少关于由ARB引起的暴发的流行病学特征和有效的感染控制措施的全球概述。在本文中,我们描述了系统评估的协议,旨在对欧洲国家由ARB和感染控制措施引起的暴发流行病学方面进行定位和特征分析。方法和分析:将使用3步搜索策略搜索MEDLINE,Web of Knowledge和Cochrane库。 2名审阅者将使用预定义的资格标准来选择要收录的文章。如果所有研究设计都报告了爆发并定义了用于微生物鉴定的微生物方法,则将包括在内。目标细菌将是耐甲氧西林和耐万古霉素的金黄色葡萄球菌,耐万古霉素的肠球菌,耐头孢他啶和耐碳青霉烯的鲍曼不动杆菌,耐头孢他啶和耐碳青霉烯的铜绿假单胞菌,扩展环丙酸杆菌,环丙沙星产生内酰胺酶的大肠杆菌和肺炎克雷伯菌,耐碳青霉烯和产生碳青霉烯酶的肠杆菌科。将使用量身定制的先导测试表格提取数据,并使用ORION(医院内感染的暴发报告和干预研究)工具评估报告的质量。数据将按照ARB的类型,设置和国家/地区进行综合和报告。将描述感染控制措施和措施捆绑。有效性将按照作者的定义进行报告。回归分析将用于定义与爆发控制相关的独立因素。研究之间的异质性将通过林地和I(2)统计数据进行评估。道德与传播:伦理批准不适用于本研究。研究结果将通过期刊出版,会议介绍和演讲进行传播。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号